Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing
Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C
Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245